Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 21545633)

1.

Cola beverage and delayed elimination of methotrexate.

Santucci R, Levêque D, Herbrecht R.

Br J Clin Pharmacol. 2010 Nov;70(5):762-4. doi: 10.1111/j.1365-2125.2010.03744.x.

2.

Carbonated beverages and chronic kidney disease.

Saldana TM, Basso O, Darden R, Sandler DP.

Epidemiology. 2007 Jul;18(4):501-6.

3.

Changes in urinary magnesium, citrate, and oxalate levels due to cola consumption.

Weiss GH, Sluss PM, Linke CA.

Urology. 1992 Apr;39(4):331-3.

PMID:
1557843
4.

Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study.

Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP.

Am J Clin Nutr. 2006 Oct;84(4):936-42.

6.

Low serum lithium associated with immoderate use of Coca-Cola Zero.

Kralovec K, Fartacek R, Plöderl M, Fartacek C, Aichhorn W.

J Clin Psychopharmacol. 2011 Aug;31(4):543-4. doi: 10.1097/JCP.0b013e318222bb44. No abstract available.

PMID:
21720234
7.

Influence of an acidic beverage (Coca-Cola) on the pharmacokinetics of phenytoin in healthy rabbits.

Kondal A, Garg SK.

Methods Find Exp Clin Pharmacol. 2003 Dec;25(10):823-5.

PMID:
14735231
8.

Delayed elimination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population.

Bauters T, Lammens T, Belin P, Benoit Y, Robays H, de Moerloose B.

Leuk Lymphoma. 2013 May;54(5):1094-6. doi: 10.3109/10428194.2012.737918. Epub 2012 Nov 15. No abstract available.

PMID:
23061529
9.

Carbonated beverages and urinary calcium excretion.

Heaney RP, Rafferty K.

Am J Clin Nutr. 2001 Sep;74(3):343-7.

10.

[Management recommendations in patients with methotrexate intoxication].

Schellens JH, Beijnen JH.

Ned Tijdschr Geneeskd. 2007 Feb 10;151(6):337-41. Dutch.

PMID:
17352296
11.

Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.

Krause AS, Weihrauch MR, Bode U, Fleischhack G, Elter T, Heuer T, Engert A, Diehl V, Josting A.

Leuk Lymphoma. 2002 Nov;43(11):2139-43.

PMID:
12533039
12.

Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.

Santucci R, Levêque D, Kemmel V, Lutz P, Gérout AC, N'guyen A, Lescoute A, Schneider F, Bergerat JP, Herbrecht R.

Anticancer Res. 2010 Mar;30(3):963-5.

PMID:
20393020
13.

Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.

Ikeda H, Kihira K, Kuwata N, Arai S, Kimura Y, Miyake K, Kitaura T, Fujimura K, Kuramoto A, Fukuchi H.

Hiroshima J Med Sci. 1996 Jun;45(2):57-62.

PMID:
8810132
14.

[Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].

Xu WQ, Tang YM, Fang CQ, Song H, Shi SW, Yang SL, Ren DT, Shen HQ, Qian BQ.

Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):15-8. Chinese.

PMID:
15946502
15.

Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.

van den Bongard HJ, Mathĵt RA, Boogerd W, Schornagel JH, Soesan M, Schellens JH, Beijnen JH.

Cancer Chemother Pharmacol. 2001 Jun;47(6):537-40.

PMID:
11459208
16.
17.

Effect of soft drinks on proximal plaque pH at normal and low salivary secretion rates.

Johansson AK, Lingström P, Birkhed D.

Acta Odontol Scand. 2007 Nov;65(6):352-6.

PMID:
18071957
18.

[Managing methotrexate toxicity: a case report].

Fernández Megía MJ, Alós Almiñana M, Terol Castera MJ.

Farm Hosp. 2004 Sep-Oct;28(5):371-4. Spanish.

19.

Immediate erosive potential of cola drinks and orange juices.

Jensdottir T, Holbrook P, Nauntofte B, Buchwald C, Bardow A.

J Dent Res. 2006 Mar;85(3):226-30.

PMID:
16498068
20.

A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination.

Hulot JS, Villard E, Maguy A, Morel V, Mir L, Tostivint I, William-Faltaos D, Fernandez C, Hatem S, Deray G, Komajda M, Leblond V, Lechat P.

Pharmacogenet Genomics. 2005 May;15(5):277-85.

PMID:
15864128
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk